New insights into the mechanism of arsenite methylation with the recombinant human arsenic (+3) methyltransferase (hAS3MT)

Biochimie

Volumn 92, Issue 10, 2010, Pages 1397-1406

  Song, Xiaoli ^a   Geng, Zhirong ^a   Li, Xiangli ^a   Hu, Xin ^b   Bian, Ningsheng ^a   Zhang, Xinrong ^c   Wang, Zhilin ^a  

^a NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

Arsenite; Enzymatic methylation; Kinetics; Mechanism; Spectroscopy

Indexed keywords

ARSENIC TRIOXIDE; DISULFIDE; GLUTATHIONE; S ADENOSYLMETHIONINE; THIOL DERIVATIVE;

ARTICLE; CHEMICAL BINDING; CHEMICAL BOND; CHEMICAL REACTION; CIRCULAR DICHROISM; ENZYME ACTIVITY; HUMAN; METHYLATION; OXIDATION; PH; PROTEIN INTERACTION; PROTON TRANSPORT; SPECTROSCOPY;

ARSENITES; DISULFIDES; GLUTATHIONE; HUMANS; KINETICS; METHYLATION; METHYLTRANSFERASES; S-ADENOSYLMETHIONINE; SPECTRUM ANALYSIS;

EID: 77957171383     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.07.002     Document Type: Article

References (50)

1. National Research Council Essentiality and Therapeutic Uses, Arsenic in Drinking Water 1999, National Academy Press, Washington, DC, pp. 251-263.
2. Engel R.R., Smith A.H. Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch. Environ. Health 1994, 49:418-427.
3. Hu C.J., Zhang A.H., Huang H.H. Molecular pathology of skin carcinogenesis due to arsenicalism from coal-burning. Arch. Environ. Health 2003, 58:92-96.
4. Yamauchi H., Yamamura Y. Dynamic change of inorganic arsenic and methylarsenic compounds in human urine after oral intake as arsenic trioxide. Indust. Hygiene 1979, 17:79-83.
5. Crecelius E.A. Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect. 1977, 19:147-150.
6. Smith T.J., Crecelius E.A., Reading J.C. Airborne arsenic exposure and excretion of methylated arsenic compounds. Environ. Health Perspect. 1977, 19:89-93.
7. Cullen W.R., McBride B.C., Reglinski J. The reaction of methylarsenicals with thiols: some biological implications. J. Inorg. Biochem. 1984, 21:179-194.
8. Hayakawa T., Kobayashi Y., Cui X., Hirano S. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. 2005, 79:183-191.
9. Yamauchi H., Fowler B.A. Toxicity and metabolism of inorganic and methylated arsenicals. Arsenic in the Environment, Part II: Human Health and Ecosystem Effects 1994, 35-43. Wiley, New York. J.O. Nriagu (Ed.).
10. Hirano S., Cui X., Li S., Kanno S., Kobayashi Y., Hayakawa T., Shraim A. Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch. Toxicol. 2003, 77:305-312.
11. Vega L., Styblo M., Patterson R., Cullen W., Wang C., Germolec D. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 2001, 172:225-232.
12. Mass M.J., Tennant A., Roop B.C., Cullen W.R., Styblo M., Thomas D.J., Kligerman A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 2001, 14:355-361.
13. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74:289-299.
14. Styblo M., Serves S.V., Cullen W.R., Thomas D.J. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 1997, 10:27-33.
15. Lin S., Del Razo L.M., Styblo M., Wang C., Cullen W.R., Thomas D.J. Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem. Res. Toxicol. 2001, 14:305-311.
16. 3+) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 2001, 114:651-656.
17. Styblo M., Delnomdedieu M., Thomas D.J. Mono- and dimethylation of arsenic in rat liver cytosol in vitro. Chem.-Biol. Interact. 1996, 99:147-164.
18. Lin S., Shi Q., Nix F.B., Styblo M., Beck M.A., Herbin-Davis K.M., Hall L.L., Simeonsson J.B., Thomas D.J. A novel S-adenosyl-l-methionine:arsenic (III) methyltransferase from rat liver cytosol. J. Biol. Chem. 2002, 277:10795-10803.
19. Zakharyan R., Wu Y., Bogdan G.M., Aposhian H.V. Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 1995, 8:1029-1038.
20. Geng Z.R., Song X.L., Xing Z., Geng J.L., Zhang S.C., Zhang X.R., Wang Z.L. Effects of selenium on the structure and function of recombinant human S-adenosyl-l-methionine dependent arsenic (+3 oxidation state) methyltransferase in E. coli. J. Biol. Inorg. Chem. 2009, 14:485-496.
21. Kedderis G.L., Elmore A.R., Crecelius E.A., Yager J.W., Gold-sworthy T.L. Kinetics of arsenic methylation by freshly isolated B6C3F1 mouse hepatocytes. Chem.-Biol. Interact. 2006, 161:139-145.
22. III-methyltransferase and the methylation of arsenite by rat and human hepatocytes. Chem. Res. Toxicol. 2003, 16:261-265.
23. Naranmandura H., Suzuki N., Suzuki K.T. Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol. 2006, 19:1010-1018.
24. Marafante E., Vahter M., Envall J. The role of the methylation in the detoxification of arsenate in the rabbit. Chem.-Biol. Interact. 1985, 56:225-238.
25. Hirata M., Hisanaga A., Tanaka A., Ishinishi N. Glutathione and methylation of inorganic arsenic in hamsters. Appl. Organoment. Chem. 1988, 2:315-321.
26. Lerman S., Clarkson T.W. The metabolism of arsenite and arsenate by the rat. Fundam. Appl. Toxicol. 1983, 3:309-314.
27. Kuroki T., Matsushima T. Performance of short-term tests for detection of human carcinogens. Mutagenesis 1987, 2:33-37.
28. Yang Y.T., Wu C.S.C., Martinez H.M. Calculation of protein conformation form circular dichroism. Methods Enzymol. 1986, 130:208-257.
29. Song X.L., Geng Z.R., Zhu J.S., Li C.Y., Hu X., Bian N.S., Zhang X.R., Wang Z.L. Structure-function roles of four cysteine residues in the human arsenic (+3 oxidation state) methyltransferase (hAS3MT) by site-directed mutagenesis. Chem.-Biol. Interact. 2009, 179:321-328.
30. Hall L.L., George S.E., Kohan M.J., Styblo M., Thomas D.J. In vitro methylation of inorganic arsenic in mouse intestinal cecum. Toxicol. Appl. Pharmacol. 1997, 147:101-109.
31. Aposhian H.V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Ann. Rev. Pharmacol. Toxicol. 1997, 37:397-419.
32. Turpeinen R., Pantsar-Kallio M., Haggblom M., Kairesalo T. Influence of microbes on the mobilization, toxicity and biomethylation of arsenic in soil. Sci. Total. Environ. 1999, 236:173-180.
33. Raab A., Feldmann J. Microbial transformation of metals and metalloids. Sci. Prog. 2003, 86:179-202.
34. Buchet J.P., Lauwerys R. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch. Toxicol. 1985, 57:125-129.
35. Styblo M., Del Razo L.M., LeCluyse E.L., Hamilton G.A., Wang C.Q., Cullen W.R., Thomas D.J. Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem. Res. Toxicol. 1999, 12:560-565.
36. Buchet J.P., Lauwerys R. Role of thiols in the in-vitro methylation of inorganic arsenic by rat liver cytosol. Biochem. Pharmacol. 1988, 37:3149-3153.
37. Waters S.B., Devesa V., Del Razo L.M., Styblo M., Thomas D.J. Endogenous reductants support the catalytic function of recombinant rat Cyt19, an arsenic methyltransferase. Chem. Res. Toxicol. 2004, 17:404-409.
38. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002, 181-182:211-217.
39. Thomas D.J., Li J., Waters S.B., Xing W., Adair B.M., Drobna Z., Devesa V., Styblo M. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp. Biol. Med. 2007, 232:3-13.
40. Spuches A.M., Kruszyna H.G., Rich A.M., Wilcox D.E. Thermodynamics of the As(III)-thiol interaction: arsenite and monomethylarsenite complexes with glutathione, dihydrolipoic acid, and other thiol ligands. Inorg. Chem. 2005, 44:2964-2972.
41. Cleland W.W. Enzyme kinetics. Annu. Rev. Biochem. 1967, 36:77-112.
42. Myllyla R., Tuderman L., Kivirikko K. Mechanism of the prolyl hydroxylase reaction. Eur. J. Biochem. 1977, 80:349-357.
43. Francis D.M., Thompson M.F., Greaves M.W. The kinetic properties and reaction mechanism of histamine methyltransferase from human skin. Biochem. J. 1980, 187:819-828.
44. Jeffery D.R., Roth J.A. Purification and kinetic mechanism of human brain soluble catechol-O-methyltransferase. J. Neurochem. 1985, 44:881-885.
45. Rivett A.J., Roth J.A. Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol O-methyltransferaset. Biochemistry 1982, 21:1740-1742.
46. Reich N.O., Mashhoon N. Kinetic mechanism of the EcoRI DNA methyltransferase. Biochemistry 1991, 30:2933-2939.
47. Reitz R.C., Mead D.J., Welch W.H. Phospholipid methylation in brain membrane preparations: kinetic mechanism. Biochim. Biophys. Acta 1993, 1166:139-144.
48. Reitz R.C., Mead D.J., Bjur R.A., Greenhouse A.H., Welch W.H. Phosphatidylethanolamine N-methyltransferase in human red blood cell membrane preparations. J. Biol. Chem. 1989, 264:8097-8106.
49. Waters S.B., Devesa V., Fricke M.W., Creed J.T., Styblo M., Thomas D.J. Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine. Chem. Res. Toxicol. 2004, 17:1621-1629.
50. Fomenko D.E., Xing W.B., Adair B.M., Thomas D.J., Gladyshev V.N. High-throughput identification of catalytic redox-active cysteine residues. Science 2007, 315:387-389.